H vs STRO
Hyatt Hotels Corporation (H) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Hyatt Hotels Corporation (H) is a lodging company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported H revenue for 2024-12-31 was $6.65B. Net income was $1.30B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. H currently screens at market cap $17.08B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
H currently screens at market cap $17.08B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the H and STRO stock pages for the full models.
Not investment advice.